Nurix Therapeutics to Participate in Upcoming Investor Conferences

April 3, 2024

https://www.globenewswire.com/news-release/2024/04/03/2856786/0/en/Nurix-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

SAN FRANCISCO, April 03, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq:NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today announced that Arthur T. Sands, M.D, Ph.D., president and chief executive officer of Nurix, Hans van Houte, Nurix’s chief financial officer, and Jason Kantor, Ph.D., Nurix’s chief business officer, will participate in the following conferences in April:

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.